In the current study, CRP and IL-6 levels measured three years later in the same cohort were also higher in patients with metabolic syndrome but did not pass cutoffs for statistical significance (p<0.08 for CRP and p<0.13 for IL-6). The gene discussed is IL6; the disease is metabolic syndrome.